Two-fraction Ultrahypofractionated Radiotherapy with focal BOost for intermediate-risk, localized prostate cancer (TURBO): study protocol of a phase II, randomized controlled clinical trial

Abstract Background Hypofractionation in prostate cancer radiotherapy (RT) has drastically reduced fractionation schemes from 35 to 5 fractions for patients with intermediate-risk prostate cancer, providing good oncological outcomes and well-tolerated treatment toxicity. With an ageing population an...

詳細記述

書誌詳細

主要な著者:	T. A. Lalmahomed, E. M. Monninkhof, M. J. van Rijssel, H. H. E. van Melick, H. M. Verkooijen, J. C. J. de Boer, J. R. N. van der Voort van Zyp
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2025-12-01
シリーズ:	Trials
主題:	MR-guided adaptive radiotherapy Quality of life Patient-reported outcomes Prostate cancer Ultrahypofractionation
オンライン･アクセス:	https://doi.org/10.1186/s13063-025-09297-5
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!